Multi-omic profiling of the leukemic microenvironment shows bone marrow interstitial fluid is distinct from peripheral blood plasma

Lorenz Nierves; Jian Guo; Siyuan Chen; Janice Tsui; Anuli C Uzozie; Jonathan W Bush; Tao Huan; Philipp F Lange

doi:10.1186/s40164-022-00310-0

Multi-omic profiling of the leukemic microenvironment shows bone marrow interstitial fluid is distinct from peripheral blood plasma

Exp Hematol Oncol. 2022 Sep 15;11(1):56. doi: 10.1186/s40164-022-00310-0.

Authors

Lorenz Nierves^{1

2}, Jian Guo³, Siyuan Chen^{1

2}, Janice Tsui^{1

2}, Anuli C Uzozie^{1

2}, Jonathan W Bush¹, Tao Huan³, Philipp F Lange^{4

5}

Affiliations

¹ Department of Pathology, University of British Columbia, Vancouver, BC, Canada.
² Michael Cuccione Childhood Cancer Research Program at the BC Children's Hospital Research Institute, Vancouver, BC, Canada.
³ Department of Chemistry, University of British Columbia, Vancouver, BC, Canada.
⁴ Department of Pathology, University of British Columbia, Vancouver, BC, Canada. philipp.lange@ubc.ca.
⁵ Michael Cuccione Childhood Cancer Research Program at the BC Children's Hospital Research Institute, Vancouver, BC, Canada. philipp.lange@ubc.ca.

Abstract

Background: The bone marrow is the place of hematopoiesis with a microenvironment that supports lifelong maintenance of stem cells and high proliferation. It is not surprising that this environment is also favourable for malignant cells emerging in the bone marrow or metastasizing to it. While the cellular composition of the bone marrow microenvironment has been extensively studied, the extracellular matrix and interstitial fluid components have received little attention. Since the sinusoids connect the bone marrow interstitial fluid to the circulation, it is often considered to have the same composition as peripheral blood plasma. Stark differences in the cellular composition of the bone marrow and peripheral blood with different secretory capacities would however suggest profound differences.

Methods: In this study we set out to better define if and how the bone marrow interstitial fluid (BMIF) compares to the peripheral blood plasma (PBP) and how both are remodeled during chemotherapy. We applied a multi-omic strategy to quantify the metabolite, lipid and protein components as well as the proteolytic modification of proteins to gain a comprehensive understanding of the two compartments.

Results: We found that the bone marrow interstitial fluid is clearly distinct from peripheral blood plasma, both during active pediatric acute lymphoblastic leukemia and following induction chemotherapy. Either compartment was shaped differently by active leukemia, with the bone marrow interstitial fluid being rich in extracellular vesicle components and showing protease dysregulation while the peripheral blood plasma showed elevation of immune regulatory proteins. Following chemotherapy, the BMIF showed signs of cellular remodeling and impaired innate immune activation while the peripheral blood plasma was characterized by restored lipid homeostasis.

Conclusion: This study provides a comprehensive examination of the fluid portion of the acute lymphoblastic leukemia microenvironment and finds the contribution of either microenvironment to tumourigenesis.

Keywords: Acute lymphoblastic leukemia; Bone marrow interstitial fluid; Microenviroment; Peripheral blood plasma.

Grants and funding

PJT-169190/CAPMC/ CIHR/Canada